BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37178249)

  • 1. Chitosan-Albumin Nanocomposite as a Promising Nanocarrier for Efficient Delivery of Fluconazole Against Vaginal Candidiasis.
    Hatamiazar M; Mohammadnejad J; Khaleghi S
    Appl Biochem Biotechnol; 2024 Feb; 196(2):701-716. PubMed ID: 37178249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model.
    Gomaa SE; Abbas HA; Mohamed FA; Ali MAM; Ibrahim TM; Abdel Halim AS; Alghamdi MA; Mansour B; Chaudhary AA; Elkelish A; Boufahja F; Hegazy WAH; Yehia FAA
    BMC Microbiol; 2024 Feb; 24(1):54. PubMed ID: 38341568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of ZnO nanoparticles coated by chitosan-linoleic acid; fungal growth and biofilm assay.
    Barad S; Roudbary M; Omran AN; Daryasari MP
    Bratisl Lek Listy; 2017; 118(3):169-174. PubMed ID: 28319414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
    Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
    J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
    Alvendal C; Mohanty S; Bohm-Starke N; Brauner A
    PLoS One; 2020; 15(9):e0238428. PubMed ID: 32941438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
    González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
    Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine-fluconazole microparticle-based combination therapy to treat candidiasis infections.
    Simões Gobbi LP; Costa EHE; Fernandez CMM; Lorenzetti FB; Fonseca DP; Gomes AV; Baldoqui DC; Fernandes CS; Ueda-Nakamura T; Nakamura CV; Lima MMS; Filho BPD
    J Appl Microbiol; 2023 Dec; 134(12):. PubMed ID: 38040656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
    de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
    J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Preclinical Study of Galloylquinic Acid Compounds from
    Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
    Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model.
    da Silva JT; Dantas de Sousa PH; Costa AF; de Menezes LB; Alves SF; Pellegrini F; Amaral AC
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37947253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Antifungal Activity of Chitosan with Fluconazole against
    Lo WH; Deng FS; Chang CJ; Lin CH
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33153228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pH-tuned chitosan-PLGA nanocarrier for fluconazole delivery reduces toxicity and improves efficacy against resistant Candida.
    Kolge H; Patil G; Jadhav S; Ghormade V
    Int J Biol Macromol; 2023 Feb; 227():453-461. PubMed ID: 36543294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
    Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.